Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
- Revenue
- +3.95%
- EPS
- +34.8%
- Free cash flow
- −7.09%
- Total debt
- +15.6%
Quarter to September 2026, against a year earlier
Follow HSIC
Alert me
Henry Schein, Inc. (HSIC) Price to free cash flow
As of 5 November 2026, Henry Schein, Inc. (HSIC) trades at a price to free cash flow of 17.0×. Over the past ten years it has ranged from 9.7× (April 2020) to 29.8× (February 2024); the current reading is higher than 34% of that period. That is below the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 15.9× | 27.14% |
| FY2024 | 12.5× | (55.17%) |
| FY2023 | 28.0× | 30.62% |
| FY2022 | 21.4× | 24.35% |
| FY2021 | 17.2× | (0.64%) |
| FY2020 | 17.3× | 1.50% |
| FY2019 | 17.1× | 12.59% |
| FY2018 | 15.2× | (15.75%) |
| FY2017 | 18.0× | 5.35% |
| FY2016 | 17.1× | (9.64%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 16.7× | 0.37% |
| Jun 2026 | 16.7× | (12.52%) |
| Mar 2026 | 19.0× | 19.46% |
| Dec 2025 | 15.9× | (19.50%) |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| COSM Cosmos Health Inc. compare | n/m |
| CAH Cardinal Health, Inc. compare | 13.6× |
| COR Cencora, Inc. compare | 16.7× |
| HSIC Henry Schein, Inc. | 17.0× |
| MCK McKesson Corporation compare | 18.2× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement